Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probiotics in hepatology: An update
Roman Maslennikov, В. Т. Ивашкин, Irina Efremova, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 9, pp. 1154-1166
Open Access | Times Cited: 23

Showing 23 citing articles:

Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis
Roman Maslennikov, Elena Poluektova, O. Yu. Zolnikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16502-16502
Open Access | Times Cited: 24
Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial
В. Т. Ивашкин, В. В. Фомин, Sergey Moiseev, et al.
Probiotics and Antimicrobial Proteins (2021) Vol. 15, Iss. 3, pp. 460-468
Open Access | Times Cited: 49
Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
Silvia Espina, Diego Casas Deza, Vanesa Bernal Monterde, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3487-3487
Open Access | Times Cited: 21
Gut microbiota analysis in cirrhosis and non-cirrhotic portal hypertension suggests that portal hypertension can be main factor of cirrhosis-specific dysbiosis
K. А. Gulyaeva, M. Yu. Nadinskaia, Roman Maslennikov, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
Roman Maslennikov, Aliya Alieva, Elena Poluektova, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 27, pp. 4236-4251
Open Access | Times Cited: 15
Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?
Roman Maslennikov, В. Т. Ивашкин, Irina Efremova, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 31, pp. 9320-9332
Open Access | Times Cited: 28
The History and Prediction of Prebiotics and Postbiotics: A Patent Analysis
Tao Zang, Lu Han, Zhaoxiang Lu, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 380-380
Open Access | Times Cited: 3
Lactobacillus gasseri LA39 promotes hepatic primary bile acid biosynthesis and intestinal secondary bile acid biotransformation
Jun Hu, Qiliang Hou, Wenyong Zheng, et al.
Journal of Zhejiang University SCIENCE B (2023) Vol. 24, Iss. 8, pp. 734-748
Open Access | Times Cited: 9
Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial
Roman Maslennikov, Irina Efremova, В. Т. Ивашкин, et al.
World Journal of Hepatology (2022) Vol. 14, Iss. 8, pp. 1667-1677
Open Access | Times Cited: 14
Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value
Zhen-Jiao Li, Hong-Zhong Gou, Yulin Zhang, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 44, pp. 6213-6229
Open Access | Times Cited: 14
Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study
Yugang Fu, Jiacheng Li, Yingying Zhu, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis
Irina Efremova, Roman Maslennikov, Elena Poluektova, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2202-2202
Open Access | Times Cited: 7
Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial
Aleksandra Kovaleva, Elena Poluektova, Roman Maslennikov, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 6064-6064
Open Access | Times Cited: 5
The Interplay Between Depression, Probiotics, Diet, Immunometabolic Health, the Gut, and the Liver—A Secondary Analysis of the Pro-Demet Randomized Clinical Trial
Oliwia Gawlik-Kotelnicka, Jakub Rogalski, Karolina H. Czarnecka, et al.
Nutrients (2024) Vol. 16, Iss. 23, pp. 4024-4024
Open Access | Times Cited: 1
Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis
Dmitry Victorovich Garbuzenko
World Journal of Hepatology (2023) Vol. 15, Iss. 4, pp. 525-537
Open Access | Times Cited: 3
Probiotic Influences on Motor Skills: A Review
Robert Lalonde, C. Strazielle
Current Neuropharmacology (2023) Vol. 21, Iss. 12, pp. 2481-2486
Open Access | Times Cited: 2
Pediococcus pentosaceus Endocarditis in a Patient With Recent Transcatheter Aortic Valve Implantation and Liver Cirrhosis: A Case Report and Review of the Literature
Petros G. Mantzios, Panagiota Spyropoulou, Sophia Hatzianastasiou, et al.
Cureus (2024)
Open Access
Effect of Saccharomyces boulardii on Liver Diseases: A Systematic Review
Roman Maslennikov, Nona Benuni, Anna Levshina, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1678-1678
Open Access
Review: Microbial Therapeutics for Liver Disease
Cyriac Abby Philips, Philip Augustine
JOURNAL OF GASTROINTESTINAL INFECTIONS (2023) Vol. 13, Iss. 01, pp. 001-016
Open Access | Times Cited: 1
Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potential
Dmitry Victorovich Garbuzenko
Russian Journal of Evidence-Based Gastroenterology (2022) Vol. 11, Iss. 4, pp. 65-65
Closed Access | Times Cited: 1
Влияние курсового приема L-орнитин- L-аспартата на фиброз и стеатоз печени у больных ассоциированной с нарушениями метаболизма жировой болезнью печени (неалкогольной жировой болезнью печени), имеющих гипераммониемию
Е. V. Garanina
Russian Journal of Gastroenterology Hepatology Coloproctology (2021) Vol. 31, Iss. 4, pp. 31-36
Open Access | Times Cited: 1

Abby Cyriac, Philip Augustine
JOURNAL OF GASTROINTESTINAL INFECTIONS (2023) Vol. 13, Iss. 01
Open Access
Des probiotiques pour l’encéphalopathie hépatique
Germán Soriano
HEGEL - HEpato-GastroEntérologie Libérale (2022) Vol. N° 1, Iss. 1, pp. 19-26
Open Access
Page 1

Scroll to top